Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
Items 201–300 of 1,001
Amygdala Atrophy in Alzheimer's Disease: An In Vivo Magnetic Resonance Imaging Study
Cuénod, C.-A. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540090046009 · Cited by 172
Arendt, T., Hennig, D., Gray, J. A., & Marchbanks, R. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90193-1 · Cited by 172
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
Farah, R., Haraty, H., Salame, Z., Fares, Y., Ojcius, D. M., & Said Sadier, N. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.03.004 · Cited by 170
Cognitive Functions in a Patient With Parkinson-Dementia Syndrome Undergoing Deep Brain Stimulation
Freund, H.-J., Kuhn, J., Lenartz, D., Mai, J. K., Schnell, T., Klosterkoetter, J., & Sturm, V. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.102 · Cited by 170
Somatostatin and dementia in Parkinson's disease
Epelbaum, J., Ruberg, M., Moyse, E., Javoy-Agid, F., Dubois, B., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90277-9 · Cited by 170
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses
Rogers, Cooper, Sukovaty, Pederson, Lee, & Friedhoff (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.0460s1007.x · Cited by 170
Neural stem cell‐based treatment for neurodegenerative diseases
Kim, S. U., Lee, H. J., & Kim, Y. B. (2013) · Neuropathology · doi:10.1111/neup.12020 · Cited by 169
The Basal Forebrain Cholinergic Projection System in Mice
Zaborszky, L., van den Pol, A., & Gyengesi, E. (2012) · The Mouse Nervous System · doi:10.1016/b978-0-12-369497-3.10028-7 · Cited by 169
Light and Electron Microscopic Localization of Presenilin-1 in Primate Brain
Lah, J. J., Heilman, C. J., Nash, N. R., Rees, H. D., Yi, H., Counts, S. E., & Levey, A. I. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-06-01971.1997 · Cited by 168
“…most intensely stained cells correspond to populations vulnerable to pathological changes in AD, including neocortical and hippocampal pyramidal neurons and magnocellular basal forebrain neurons (Terry et al., 1981; Whitehouse et al., 1981; Hof et al., 1990), PS1 is not limited to these cell types.”
BackgroundBoyd-Kimball, D., Sultana, R., Fai Poon, H., Lynn, B. C., Casamenti, F., Pepeu, G., Klein, J. B., & Butterfield, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.022 · Cited by 166
Targeted Vagus Nerve Stimulation for Rehabilitation After Stroke
Engineer, N. D., Kimberley, T. J., Prudente, C. N., Dawson, J., Tarver, W. B., & Hays, S. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00280 · Cited by 165
Fabiani, C., & Antollini, S. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00309 · Cited by 154
Neuropeptide Y receptors in rat brain: Autoradiographic localization
Martel, J.-C., St-Pierre, S., & Quirion, R. (1986) · Peptides · doi:10.1016/0196-9781(86)90061-6 · Cited by 163
Sarter, M., Bruno, J. P., & Dudchenko, P. (1990) · Psychopharmacology · doi:10.1007/bf02253710 · Cited by 162
Fisher, R. S., Buchwald, N. A., Hull, C. D., & Levine, M. S. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902720404 · Cited by 161
Basal forebrain volume reliably predicts the cortical spread of Alzheimer’s degeneration
Fernández‐Cabello, S., Kronbichler, M., Dijk, K. R. A. V., Goodman, J. A., Spreng, R. N., Schmitz, T. W., & Initiative, O. B. O. T. A. D. N. (2020) · Brain · doi:10.1093/brain/awaa012 · Cited by 209
Moberg, P. J., Pearlson, G. D., Speedie, L. J., Lipsey, J. R., Strauss, M. E., & Folstein, S. E. (1987) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638708405208 · Cited by 157
ALZHEIMER'S DISEASE AND RELATED DISORDERS
Raskind, M. A., & Peskind, E. R. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70341-2 · Cited by 161
McGaughy, J., Everitt, B. J., Robbins, T. W., & Sarter, M. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00262-x · Cited by 159
Antioxidant Therapy in Alzheimers Disease: Theory and Practice
Aliev, G., Obrenovich, M., Reddy, V., Shenk, J., Moreira, P., Nunomura, A., Zhu, X., Smith, M., & Perry, G. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369582 · Cited by 159
Grothe, M. J., Schuster, C., Bauer, F., Heinsen, H., Prudlo, J., & Teipel, S. J. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7439-z · Cited by 168
Inhibition of Human Cholinesterases by Drugs Used to Treat Alzheimer Disease
Darvesh, S., Walsh, R., Kumar, R., Caines, A., Roberts, S., Magee, D., Rockwood, K., & Martin, E. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200304000-00011 · Cited by 158
THE NUCLEUS BASALIS IN ALZHEIMER'S DISEASE: CELL COUNTS AND CORTICAL BIOCHEMISTRY
WILCOCK, G. K., ESIRI, M. M., BOWEN, D. M., & SMITHS, C. C. T. (1983) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1983.tb00105.x · Cited by 157
Neurovascular function in Alzheimer's disease patients and experimental models
Nicolakakis, N., & Hamel, E. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.43 · Cited by 156
“The basal forebrain cholinergic system degenerates (Whitehouse et al, 1981; Sassin et al, 2000) along with noradrenaline-containing neurons of the locus coeruleus (Tomlinson et al, 1981), and there are decreases in levels of dopaminergic, serotoninergic, and somatostatin markers in various brain…”
BackgroundTeipel, S. J., Meindl, T., Grinberg, L., Grothe, M., Cantero, J. L., Reiser, M. F., Möller, H., Heinsen, H., & Hampel, H. (2011) · Human Brain Mapping · doi:10.1002/hbm.21111 · Cited by 148
Kostović, I. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90077-1 · Cited by 162
Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
Mihevc, S. P., & Majdič, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00604 · Cited by 164
The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?
Gratwicke, J., Kahan, J., Zrinzo, L. U., Hariz, M. I., Limousin, P. D., Foltynie, T., & Jahanshahi, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.003 · Cited by 162
Wenk, G. L., & Olson, D. S. (1984) · Brain Research · doi:10.1016/0006-8993(84)91468-9 · Cited by 152
Sleep suppression following kainic acid-induced lesions of the basal forebrain
Szymusiak, R. S., & McGinty, D. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90240-2 · Cited by 151
Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
Cai, Z., Zhao, Y., & Zhao, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455386 · Cited by 145
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149
Septal networks: relevance to theta rhythm, epilepsy and Alzheimer's disease
Colom, L. V. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03630.x · Cited by 142
D’Amelio, M., & Rossini, P. M. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.07.001 · Cited by 158
Montplaisir, J., Petit, D., Lorrain, D., Gauthier, S., & Nielsen, T. (1995) · Sleep · doi:10.1093/sleep/18.3.145 · Cited by 149
A Comparison of Dementia in Alzheimer's Disease and Multiple Sclerosis
Filley, C. M., Heaton, R. K., Nelson, L. M., BURKS, J. S., & Franklin, G. M. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520380061013 · Cited by 156
Experimental approaches to age-related cognitive impairments
Gage, F. H., Chen, K. S., Buzsáki, G., & Armstrong, D. L. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80129-5 · Cited by 158
Cholinergic innervation in adult rat cerebral cortex: A quantitative immunocytochemical description
Mechawar, N., Cozzari, C., & Descarries, L. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001211)428:2<305::aid-cne9>3.0.co;2-y · Cited by 147
Genetically modified cells: applications for intracerebral grafting
Gage, F. H., Kawaja, M. D., & Fisher, L. J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90156-o · Cited by 147
Diffuse Cortical Projection Systems: Anatomical Organization and Role in Cortical Function
Saper, C. B. (1987) · Comprehensive Physiology · doi:10.1002/cphy.cp010506 · Cited by 135
Polysomnographic and Subjective Sleep Markers of Mild Cognitive Impairment
Hita-Yañez, E., Atienza, M., & Cantero, J. L. (2013) · Sleep · doi:10.5665/sleep.2956 · Cited by 133
Fishman, E. B., Siek, G. C., MacCallum, R. D., Bird, E. D., Volicer, L., & Marquis, J. K. (1986) · Annals of Neurology · doi:10.1002/ana.410190305 · Cited by 146
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses
Rogers, & Friedhoff (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.0460s1001.x · Cited by 140
Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging
Araujo, J. A., Studzinski, C. M., & Milgram, N. W. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.12.008 · Cited by 153
Book, A. A., Wiley, R. G., & Schweitzer, J. B. (1992) · Brain Research · doi:10.1016/0006-8993(92)91121-t · Cited by 144
Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer’s Disease
Wang, H., & Zhang, H. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00391 · Cited by 136
Maruyama, H., Toji, H., Harrington, C. R., Sasaki, K., Izumi, Y., Ohnuma, T., Arai, H., Yasuda, M., Tanaka, C., Emson, P. C., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.236 · Cited by 155
Muscarinic and nicotinic cholinergic binding sites in alzheimer's disease cerebral cortex
Kellar, K. J., Whitehouse, P. J., Martino, A. M., Marcus, K. A., & Price, D. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)91556-3 · Cited by 149
Self-citationNicotine enhances delayed matching-to-sample performance by primates
Elrod, K., Buccafusco, J. J., & Jackson, W. J. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90318-9 · Cited by 142
Activity-dependent neurotransmitter respecification
Spitzer, N. C. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3154 · Cited by 136
Brown, R. G., Marsden, C. D., Quinn, N., & Wyke, M. A. (1984) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.5.454 · Cited by 140
Basal Forebrain Cholinergic Modulation of Sleep Transitions
Ozen Irmak, S., & de Lecea, L. (2014) · Sleep · doi:10.5665/sleep.4246 · Cited by 132
Moss, D. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103438 · Cited by 146
Moran, S. P., Maksymetz, J., & Conn, P. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.10.007 · Cited by 133
Electric activity in the neocortex of freely moving young and aged rats
Buzsáki, G., Bickford, R. G., Armstrong, D. M., Ponomareff, G., Chen, K. S., Ruiz, R., Thal, L. J., & Gage, F. H. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90095-4 · Cited by 149
Reductions in Acetylcholine and Nicotine Binding in Several Degenerative Diseases
Whitehouse, P. J., Martino, A. M., Marcus, K. A., Zweig, R. M., Singer, H. S., Price, D. L., & Kellar, K. J. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310028012 · Cited by 141
Self-citationEvidence for Cholinergic Neurites in Senile Plaques
Kitt, C. A., Price, D. L., Struble, R. G., Cork, L. C., Wainer, B. H., Becher, M. W., & Mobley, W. C. (1984) · Science · doi:10.1126/science.6505701 · Cited by 138
Self-citationIkonomovic, M. D., Mufson, E. J., Wuu, J., Cochran, E. J., Bennett, D. A., & DeKosky, S. T. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5106 · Cited by 136
Rate of forgetting in dementia and depression.
Hart, R. P., Kwentus, J. A., Taylor, J. R., & Harkins, S. W. (1987) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.55.1.101 · Cited by 152
Mann, D. M. A. (1983) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(83)90100-8 · Cited by 135
Turrini, P., Casu, M. A., Wong, T. P., De Koninck, Y., Ribeiro-da-Silva, A., & Cuello, A. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00172-5 · Cited by 135
Wenk, G. L., Parsons, C. G., & Danysz, W. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00007 · Cited by 128
Serotonin nerve cells in Alzheimer's disease.
Mann, D. M. A., & Yates, P. O. (1983) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.1.96 · Cited by 144
Quantitative histochemistry of brain acetylcholinesterase and learning rate in the aged rat
Biegon, A. R., Greenberger, V., & Segal, M. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90046-1 · Cited by 144
Mesulam, M. ‐., Volicer, L., Marquis, J. K., Mufson, E. J., & Green, R. C. (1986) · Annals of Neurology · doi:10.1002/ana.410190206 · Cited by 135
Confusion, dementia and anticholinergics in Parkinson's disease.
de Smet, Y., Ruberg, M., Serdaru, M., Dubois, B., Lhermitte, F., & Agid, Y. (1982) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.12.1161 · Cited by 133
Parnetti, L., Amenta, F., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00312-8 · Cited by 132
“…accompanied by decreased neocortical choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities, the major anabolic and catabolic enzymes for acetylcholine, respectively, was commonly reported in brains of demented subjects (Davies and Maloney, 1976; Whitehouse et al., 1981, 1982).”
BackgroundAlzheimer's disease may begin in the nose and may be caused by aluminosilicates
Roberts, E. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90119-3 · Cited by 149
Saper, C. B., & Chelimsky, T. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90286-0 · Cited by 131
Pharmacodynamic-Tolerability Relationships of Cholinesterase Inhibitors for Alzheimer??s Disease
Imbimbo, B. P. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00004 · Cited by 138
Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus
Darvesh, S., & Hopkins, D. A. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10751 · Cited by 128
Rudelli, R. D., Ambler, M. W., & Wísniewski, H. M. (1984) · Acta Neuropathologica · doi:10.1007/bf00690393 · Cited by 136
Tagliavini, F., & Pilleri, G. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90203-4 · Cited by 140
Reynolds, G. P., Arnold, L., Rossor, M. N., Iversen, L. L., Mountjoy, C. Q., & Roth, M. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90219-2 · Cited by 130
Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning
Friedman, E., Lerer, B. E., & Kuster, J. E. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90057-6 · Cited by 129
Cortical vs Subcortical Dementia: Neuropsychological Differences
Huber, S. J. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520040072023 · Cited by 126
Cholinergic activity and amyloid precursor protein metabolism
Roberson, M. R., & Harrell, L. E. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00016-7 · Cited by 137
Christensen, D. Z., Kraus, S. L., Flohr, A., Cotel, M.-C., Wirths, O., & Bayer, T. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0451-6 · Cited by 126
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
BackgroundThe human basal forebrain. Part II
Heimer, L., de Olmos, J. S., Alheid, G. F., Pearson, J., Sakamoto, N., Shinoda, K., Marksteiner, J., & Switzer, R. C. (1999) · Handbook of Chemical Neuroanatomy · doi:10.1016/s0924-8196(99)80024-4 · Cited by 125
Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice
Kim, E., Jung, I.-H., Le, T. K. V., Jeong, J.-J., Kim, N., & Kim, D. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.12.047 · Cited by 126
Beaulieu, C., & Somogyi, P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903040412 · Cited by 126
Retrograde cell degeneration in the basal nucleus in monkey and man
Pearson, R. C. A., Gatter, K. C., & Powell, T. P. S. (1983) · Brain Research · doi:10.1016/0006-8993(83)90637-6 · Cited by 125
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease
Cutler, N. R., Polinsky, R. J., Srarnek, J. J., Enz, A., Jhee, S. S., Mancione, L., Hourani, J., & Zolnouni, P. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00645.x · Cited by 122
Rice, D. P., Fillit, H. M., Max, W. B., Knopman, D. S., Lloyd, J. R., & Duttagupta, S. (2001) · PubMed · Cited by 144
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A antibody
Bales, K. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27120 · Cited by 120
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
Wong, K. Y., Roy, J., Fung, M. L., Heng, B. C., Zhang, C., & Lim, L. W. (2020) · Aging and disease · doi:10.14336/ad.2019.1125 · Cited by 119
Mesulam, M. M. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)62112-3 · Cited by 143
Chapter 29 Neuropathological changes in Alzheimer disease
Terry, R. D. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61964-0 · Cited by 143
Kabir, M. T., Uddin, M. S., Begum, M. M., Thangapandiyan, S., Rahman, M. S., Aleya, L., Mathew, B., Ahmed, M., Barreto, G. E., & Ashraf, G. M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191008103141 · Cited by 116
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
Mazzola, C., Micale, V., & Drago, F. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.026 · Cited by 122
Inestrosa, N. C., Marzolo, M., & Bonnefont, A. (1998) · Molecular Neurobiology · doi:10.1007/bf02802025 · Cited by 137
Basal Forebrain Infarction: A Clinicopathologic Correlation
Phillips, S. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520230024008 · Cited by 121
Loganin improves learning and memory impairments induced by scopolamine in mice
Kwon, S., Kim, H., Lee, S., & Jang, C. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.062 · Cited by 122
Hita-Yanez, E., Atienza, M., Gil-Neciga, E., & L. Cantero, J. (2012) · Current Alzheimer Research · doi:10.2174/156720512800107609 · Cited by 114
The primate temporal pole: its putative role in object recognition and memory
Nakamura, K., & Kubota, K. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00227-8 · Cited by 129
Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat
Baskerville, K. A., Schweitzer, J. B., & Herron, P. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00064-x · Cited by 133
Jonnala, R. R., & Buccafusco, J. J. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10022 · Cited by 120
Theofilas, P., Dunlop, S., Heinsen, H., & Grinberg, L. T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142682 · Cited by 114
Salvia miltiorrhiza: A source for anti-Alzheimer’s disease drugs
Zhang, X., Qian, S., Zhang, Y.-J., & Wang, R. L. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1027408 · Cited by 126
Brain aging and Alzheimer's disease; use it or lose it
Swaab, D. F., Dubelaar, E. J. G., Hofman, M. A., Scherder, E., Someren, E. J. W. V., & Verwer, R. W. H. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)38086-5 · Cited by 124
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.